Request for Product Trial
Procedure Description:
Minerva is the first entirely new endometrial ablation technology introduced in the last 17 years and uses a novel mechanism of action, plasma thermal conduction, over a two-minute treatment cycle to ablate the lining of the endometrium.
Advantages:
Patient Safety
Proprietary safety features include:
- visual confirmation of cervical seal prior to safety check
- CO2 extension tubes designed for greater sensitivity in detecting perforations
- maximum 40 watts of energy delivery modulated by real time impedance monitoring vs maximum 180 watts of constant power delivery
Efficacy
In comparison to the nearest competitor, Minerva demonstrated the following in FDA trials:
- highest amenorrhea rate – 72% vs 36%
- highest long term success rate – 93% vs 76%
- lowest long term hysterectomy rate – 0.91% (1 total) vs 6.3% (11 total)
- more effectively treats patients with a uterine sounding length greater than 6 cm
Ease of Use
- silicone array which inserts and removes easily
- intracervical sealing balloon
- visual touchscreen interface
We the undersigned wish to trial the Minerva endometrial ablation system for the reasons stated above.
I have used this device multiple times over the last 2 years with great results and ease of use.